a randomized, double-blinded, sham-controlled trial
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Selected patients presented RA and fulfilled the ACR 1987 criteria for diagnosis of RA.
Exclusion criteria
Exclusion criteria: Patients were excluded from the study if they received biological therapies for RA, were diagnosed with another inflammatory disease or experienced uncontrolled or clinically significant systemic diseases other than RA.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the improvement of the activity of subjects by 28-joints disease activity score based on CRP (DAS28-CRP) | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS for pain, swollen joint score, tender joint score, modified health assessment questionnaire, and changes in laboratory measures of biomarkers | — |
Countries
Japan
Contacts
Kyoto Prefectural University of Medicine Gastroenterology and Hepatology